Company intelligence / Profile preview

Certor

Princeton, New Jersey, United Statescertorsports.com ↗

Ownership: Private
Development stage: Commercial

Overview

Certara provides predictive simulation, data-driven modeling, and AI-powered solutions that accelerate drug discovery, optimize dosing strategies, streamline clinical trials, support regulatory submissions (including NDA components), and improve decision-making throughout the entire drug development lifecycle. Their expertise has contributed to successful approvals such as Biohaven’s Nurtec ODT.

Modalities: Small moleculeBiologicMonoclonal antibodyAntibody-drug conjugate
Industry: Drug Discovery Services

Partnerships

Collaborates with leading biotech companies such as BiohavenPartners with pharma companies like Arvinas

Beyond the preview

Go deeper on Certor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Certor.

Explore the full profile